Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study

Articles > Article · 2009

Authors: GV SCAGLIOTTI, K PARK, S PATIL, J ROLSKI, Tuncay GÖKSEL, R MARTINS, SJ GANS, C VISSEREN-GRUL, P PETERSON

European Journal of Cancer, Journal Indexed in SCI Expanded, International, WoS, 2009, vol 45, pp 2298-2303